Exicure teams up with Dermelix in potential $1bn rare skin disease deal
- Antisense, Oligonucleotides
Drug Discovery Tools
- Gene Therapy, Cell Therapy
- Nanotechnology, Chips, etc.
- Drug Delivery
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R+D and Marketing-Licensing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.